High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.1M
$3,102,533
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-04 | $131,609x2 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $2,762,822Largex11 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $164,298x10 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Discretionary Sell
|
2025-12-12 | $339,711 | S | Form 4 |